These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11221954)

  • 21. [Scutellaria barbata extract enhances efficacy and reduces toxicity of chemotherapy in hepatoma H22-bearing mice].
    Dai ZJ; Wang XJ; Ji ZZ; Li ZF; Tang W; Kang HF; Ma XB; Liu L
    Zhong Xi Yi Jie He Xue Bao; 2008 Jul; 6(7):720-4. PubMed ID: 18601855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.
    Miller CR; Williams CR; Buchsbaum DJ; Gillespie GY
    Cancer Res; 2002 Feb; 62(3):773-80. PubMed ID: 11830532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
    Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
    Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Long-term evaluation of chronic diabetic foot ulcers, non-healed after hyperbaric oxygen therapy].
    Albuquerque E Sousa J
    Rev Port Cir Cardiotorac Vasc; 2005; 12(4):227-37. PubMed ID: 16474863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized phase II trial of 5-fluorouracil, with or without human interferon-beta, for advanced colorectal cancer.
    Villar-Grimalt A; Candel MT; Massuti B; Lizón J; Sánchez B; Frau A; Gorostidi B; Goedkoop R
    Br J Cancer; 1999 May; 80(5-6):786-91. PubMed ID: 10360656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperoxia increases the uptake of 5-fluorouracil in mammary tumors independently of changes in interstitial fluid pressure and tumor stroma.
    Moen I; Tronstad KJ; Kolmannskog O; Salvesen GS; Reed RK; Stuhr LE
    BMC Cancer; 2009 Dec; 9():446. PubMed ID: 20017908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer.
    Wong JY; Shibata S; Williams LE; Kwok CS; Liu A; Chu DZ; Yamauchi DM; Wilczynski S; Ikle DN; Wu AM; Yazaki PJ; Shively JE; Doroshow JH; Raubitschek AA
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5842-52. PubMed ID: 14676105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antitumor effect of hyperthermia combined with fluorouracil and its analogues.
    Harada S; Ping L; Obara T; Oikawa H; Miyata M; Matsuo M; Takahashi T; Yanagisawa T
    Radiat Res; 1995 May; 142(2):232-41. PubMed ID: 7724740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I and pharmacokinetic study of weekly 5-fluorouracil administered with granulocyte-macrophage colony-stimulating factor and high-dose leucovorin: a potential role for growth factor as mucosal protectant.
    Meropol NJ; Rustum YM; Creaven PJ; Blumenson LE; Frank C
    Cancer Invest; 1999; 17(1):1-9. PubMed ID: 10999043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics, dosimetry and comparative efficacy of 188Re-liposome and 5-FU in a CT26-luc lung-metastatic mice model.
    Chen LC; Wu YH; Liu IH; Ho CL; Lee WC; Chang CH; Lan KL; Ting G; Lee TW; Shien JH
    Nucl Med Biol; 2012 Jan; 39(1):35-43. PubMed ID: 21958858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of hyperbaric oxygen therapy combined with mild hyperthermia for improving the anti-tumour effects of carboplatin.
    Ohguri T; Kunugita N; Yahara K; Imada H; Uemura H; Shinya N; Youjirou G; Takashi C; Okazaki R; Ootsuyama A; Korogi Y
    Int J Hyperthermia; 2015; 31(6):643-8. PubMed ID: 26156211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-Fluorouracil derivatives: a patent review.
    Álvarez P; Marchal JA; Boulaiz H; Carrillo E; Vélez C; Rodríguez-Serrano F; Melguizo C; Prados J; Madeddu R; Aranega A
    Expert Opin Ther Pat; 2012 Feb; 22(2):107-23. PubMed ID: 22329541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacokinetics and distribution of 5-Fu magnetic albumin deuto-microsphere in normal and tumor-bearing mice].
    Xu R; Shi SJ; Zhou SC; Zheng JW; Chen H; Zou SQ; Zeng FD
    Yao Xue Xue Bao; 2007 Jan; 42(1):66-70. PubMed ID: 17520810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug retention and distribution after intratumoral chemotherapy with fluorouracil/epinephrine injectable gel in human pancreatic cancer xenografts.
    Smith JP; Kanekal S; Patawaran MB; Chen JY; Jones RE; Orenberg EK; Yu NY
    Cancer Chemother Pharmacol; 1999; 44(4):267-74. PubMed ID: 10447573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microprocessor-controlled iontophoretic drug delivery of 5-fluorouracil: pharmacodynamic and pharmacokinetic study.
    Chandrashekar NS; Shobha Rani RH
    J BUON; 2007; 12(4):529-34. PubMed ID: 18067212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intra-aortal therapy with 5-fluorouracil- polyethylene glycol stealth liposomes: does the metabolism of 5-fluorouracil into 5-fluoro-2'-deoxyuridine depend on ph value?. An animal study in VX-2 liver tumor-bearing rabbits.
    Pohlen U; Binnenhei M; Reszka R; Buhr HJ; Berger G
    Chemotherapy; 2004 Jun; 50(2):67-75. PubMed ID: 15211080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term functional and neurological outcome after simultaneous treatment with tissue-plasminogen activator and hyperbaric oxygen in early phase of embolic stroke in rats.
    Michalski D; Küppers-Tiedt L; Weise C; Laignel F; Härtig W; Raviolo M; Schneider D; Hobohm C
    Brain Res; 2009 Dec; 1303():161-8. PubMed ID: 19766603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperbaric oxygen and radiotherapy.
    Mayer R; Hamilton-Farrell MR; van der Kleij AJ; Schmutz J; Granström G; Sicko Z; Melamed Y; Carl UM; Hartmann KA; Jansen EC; Ditri L; Sminia P
    Strahlenther Onkol; 2005 Feb; 181(2):113-23. PubMed ID: 15702300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New formulation of 5-fluorouracil in microspheres reduces toxicity in mice.
    Hagiwara A; Sakakura C; Tsujimoto H; Ohgaki M; Imanishi T; Yamazaki J; Sawai K; Takahashi T; Yamamoto A; Muranishi S; Tabata Y; Ikada Y
    Anticancer Drugs; 1996 Sep; 7(7):780-4. PubMed ID: 8949990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of vasomodulators and tumor transplantation on the disposition of 5-fluorouracil after application to the liver surface in rats.
    Kodama Y; Horishita M; Tokunaga A; Miyamoto H; Fumoto S; Sasaki H; Nakamura J; Nishida K
    Biopharm Drug Dispos; 2017 Sep; 38(6):367-372. PubMed ID: 28239866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.